|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.032 HKD | 0.00% |
|
0.00% | -11.11% |
| May. 02 | Active Gains Files Winding-Up Petition Against Kontafarma China's Subsidiary | MT |
| Apr. 19 | Kontafarma China Holdings Limited Announces Management Changes, Effect from 19 April 2024 | CI |
Kontafarma China Holdings Limited reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was HKD 894.06 million compared to HKD 803.27 million a year ago. Net loss was HKD 41.55 million compared to HKD 15.05 million a year ago.
Basic loss per share from continuing operations was HKD 0.0152 compared to HKD 0.0086 a year ago. Basic loss per share was HKD 0.0074 compared to HKD 0.0027 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -11.11% | 22.89M | |
| +21.85% | 546B | |
| -4.77% | 359B | |
| +16.97% | 323B | |
| +5.69% | 290B | |
| +13.68% | 234B | |
| +3.65% | 198B | |
| -11.12% | 194B | |
| +8.08% | 167B | |
| -3.40% | 157B |
KONTAFARMA CHINA HOLDINGS LIMITED 
